Cargando…
Use of a multi-gene pharmacogenetic panel reduces adverse drug effects
Swen et al.(1) examine the utility of multi-gene pharmacogenetic testing in a large multi-national cohort. They show fewer adverse drug reactions among patients receiving testing and prescribing recommendations based on genotype results compared with those receiving usual care.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213803/ https://www.ncbi.nlm.nih.gov/pubmed/37084734 http://dx.doi.org/10.1016/j.xcrm.2023.101021 |
| _version_ | 1785047706983464960 |
|---|---|
| author | Cavallari, Larisa H. Johnson, Julie A. |
| author_facet | Cavallari, Larisa H. Johnson, Julie A. |
| author_sort | Cavallari, Larisa H. |
| collection | PubMed |
| description | Swen et al.(1) examine the utility of multi-gene pharmacogenetic testing in a large multi-national cohort. They show fewer adverse drug reactions among patients receiving testing and prescribing recommendations based on genotype results compared with those receiving usual care. |
| format | Online Article Text |
| id | pubmed-10213803 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102138032023-05-27 Use of a multi-gene pharmacogenetic panel reduces adverse drug effects Cavallari, Larisa H. Johnson, Julie A. Cell Rep Med Spotlight Swen et al.(1) examine the utility of multi-gene pharmacogenetic testing in a large multi-national cohort. They show fewer adverse drug reactions among patients receiving testing and prescribing recommendations based on genotype results compared with those receiving usual care. Elsevier 2023-04-20 /pmc/articles/PMC10213803/ /pubmed/37084734 http://dx.doi.org/10.1016/j.xcrm.2023.101021 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Spotlight Cavallari, Larisa H. Johnson, Julie A. Use of a multi-gene pharmacogenetic panel reduces adverse drug effects |
| title | Use of a multi-gene pharmacogenetic panel reduces adverse drug effects |
| title_full | Use of a multi-gene pharmacogenetic panel reduces adverse drug effects |
| title_fullStr | Use of a multi-gene pharmacogenetic panel reduces adverse drug effects |
| title_full_unstemmed | Use of a multi-gene pharmacogenetic panel reduces adverse drug effects |
| title_short | Use of a multi-gene pharmacogenetic panel reduces adverse drug effects |
| title_sort | use of a multi-gene pharmacogenetic panel reduces adverse drug effects |
| topic | Spotlight |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213803/ https://www.ncbi.nlm.nih.gov/pubmed/37084734 http://dx.doi.org/10.1016/j.xcrm.2023.101021 |
| work_keys_str_mv | AT cavallarilarisah useofamultigenepharmacogeneticpanelreducesadversedrugeffects AT johnsonjuliea useofamultigenepharmacogeneticpanelreducesadversedrugeffects |